Very Quiet20 Jun 2023 16:39
Hi Brains.
I am watching this space as well.
I hope that the CEO gets his marketing team cranked up. With this THC based painkilling business in its infancy, nevertheless I think Celadon's capacity can be absorbed quite quickly into the market, even though they have signed up £3 mill annual sales from a potential of 90 mill.
I also hope the NHS quickly adopts this medication for regular prescription. The market would be enormous. Jim Short should be lobbying the Treasury/Health Secratary. This could help them save millions from removing the additional draw backs of opioid medicines.